
Trump’s Generic Drug Tariffs Could Affect U.S. Healthcare & Trade
President Donald Trump has unveiled a new phased policy on generic drug tariffs, aiming to restore U.S. medicine manufacturing and
President Donald Trump has unveiled a new phased policy on generic drug tariffs, aiming to restore U.S. medicine manufacturing and supply chain. …
The U.S. Food and Drug Administration (FDA) has announced a nationwide drug recall alerton the Cetirizine Hydrochloride Tablets by Unique Pharmaceutical Laboratories …
The Central Drugs Standard Control Organisation (CDSCO), under the supervision of the Drug Controller General of India (DCGI), has officially granted marketing …
The Delaware Division of Public Health (DPH) confirmed the state’s first case of measles in Delaware since 2014. The patient was identified …
The precision medicine firm Tempus AI has announced a definitive agreement to acquire Personalis Biotech for approximately $1.5 billion. With the Personalis …
Global biopharmaceutical leader Bristol Myers Squibb (BMS) has announced an expanded collaboration with technology giant NVIDIA. The Bristol Myers Squibb and NVIDIA …
The U.S. Food and Drug Administration (FDA) has approved Merck’s cholesterol pill, Lipfendra (enlicitide). Lipfendra is the first-ever FDA-approved oral PCSK9 inhibitor. …
The world’s biggest pharmaceutical company, Eli Lilly, has announced a definitive agreement to buy the clinical-stage biopharmaceutical firm AtaiBeckley. The deal is …
Sun Pharmaceutical Industries has secured marketing approval for its generic semaglutide medicine from the South African Health Products Regulatory Authority (SAHPRA). With …
The cyclosporiasis outbreak in USA continues to grow as the Centers for Disease Control and Prevention (CDC) announced that 1,645 domestically acquired …
An urgent Mt Ossa Australian Spring Water recall has been issued across select regions of the country. The Tasmanian Mountain Waters Exp …
In a milestone achievement for oncology, the biopharma giant GSK’s Jemperli cancer drug trial has met positive interim Phase II results from …

President Donald Trump has unveiled a new phased policy on generic drug tariffs, aiming to restore U.S. medicine manufacturing and

The U.S. Food and Drug Administration (FDA) has announced a nationwide drug recall alerton the Cetirizine Hydrochloride Tablets by Unique

The Central Drugs Standard Control Organisation (CDSCO), under the supervision of the Drug Controller General of India (DCGI), has officially

The Delaware Division of Public Health (DPH) confirmed the state’s first case of measles in Delaware since 2014. The patient

The precision medicine firm Tempus AI has announced a definitive agreement to acquire Personalis Biotech for approximately $1.5 billion. With

Global biopharmaceutical leader Bristol Myers Squibb (BMS) has announced an expanded collaboration with technology giant NVIDIA. The Bristol Myers Squibb

The U.S. Food and Drug Administration (FDA) has approved Merck’s cholesterol pill, Lipfendra (enlicitide). Lipfendra is the first-ever FDA-approved oral

The world’s biggest pharmaceutical company, Eli Lilly, has announced a definitive agreement to buy the clinical-stage biopharmaceutical firm AtaiBeckley. The

Sun Pharmaceutical Industries has secured marketing approval for its generic semaglutide medicine from the South African Health Products Regulatory Authority

The cyclosporiasis outbreak in USA continues to grow as the Centers for Disease Control and Prevention (CDC) announced that 1,645

An urgent Mt Ossa Australian Spring Water recall has been issued across select regions of the country. The Tasmanian Mountain

In a milestone achievement for oncology, the biopharma giant GSK’s Jemperli cancer drug trial has met positive interim Phase II